Biotech Investing Pipeline Valuation

I am new to biotech investing.

How does one normally value the pipeline of drugs for a company? The company's investor presentation gives you the drug candidates in the pipeline, but how do you know which of their candidates are more valuable? How do you begin to figure this out?

198 WSO Academy Hedge Fund Session Reviews: 4.78/5

Class of '29 Sep 2026 Cohort

5.00/5

Hedge Fund LinkedIn Review

“My meeting with Kevin Lee was super helpful and went well beyond what I originally expected. We met to discuss my LinkedIn profile, but the conversation also covered the hedge fund space and how I’m thinking about my career as a whole. I really appreciated being able to talk about both how I present myself professionally and the broader direction I want to take. As someone interested in hedge funds but also exploring other paths in finance, it was helpful to have a conversation that connected my profile to my actual interests and goals. Kevin gave me a lot to think about, and I left feeling clearer about my next steps. Overall, I really appreciated his time and willingness to go beyond the original purpose of our meeting.”

Class of '26 Sep 2026 Cohort

4.56/5

Hedge Fund Mock Interview

“He was very responsive and prepared for the meeting. He actually read the JD, resume, and looked up linkedin which sometimes other mentors doesn't actually go over those to prepare things beforehand. I appreciate his direct comments I think it saved time and actually helped me to know exactly where to improve. I also appreciated him admitting if he doesn't know about specific HF strategy. Only thing I'd suggest for him is probably sending actionable key takeaways after the meeting because other mentors did and that was very helpful. ”

See All 11,628 WSO Academy Reviews

2 Comments

WSO Monkey Bot

O

7y

Hi analyzer, hope I can help. Do any of these links cover what you're looking for:

Biotech finance part 2: valuation methodologies and modeling considerations intended for people who understand basic finance and valuation but aren't too familiar with biotech ... . If you work in a biotech group, you probably already know this. Subsequent posts will cover topics ... valuation don't show up in financial metrics- late-stage unapproved drugs can be valued at tens of ...
Guide To Evaluate a Biotech Company the biotech sector. Evaluating biotech companies to invest in cannot be done in the conventional way ... That is how money is made and lost when investing in biotech. Ex. A certain company is in the midst of ... responsibilities is being in charge of the biotech stocks in the portfolio as well as researching new opportunities ...
Biotech IB... top groups/offices? Biotech investment banking healthcare top groups banks offices ...
Biotech ER- Who prefers PhD to MBA/CFA? doing postdoc science research at a top Ivy for 5 years. I want to transition into biotech ER, and have ... been working on building up my financial modeling and valuation skills using the Wall Street Prep ... banks whose biotech teams prefer PhDs that need help with the finance/accounting at first? Put another ...
Biotech finance: from IB to VC / HF to funded startup models are BS- most valuations in biotech right now are at levels that can't be explained by ... I worked in the healthcare IB group of a lower-tier BB, then was a biotech analyst at a $1.8B ... late-stage VC / growth equity fund / public equity fund, then founded a venture-backed biotech startup. ...
Healthcare / Biotech Venture Capital? Curious about what kind of candidates healthcare and biotech-focused VCs look for. It seems like ... consulting, and BB healthcare investment banking (both at analyst level). I also have an opportunity to join ... a biotech startup instead. MBA or science master's degree are an option in the future! But the end goal ...
Biotech Equity Research with no Science background my own research it is clear that the individuals in Biotech ER come from science intensive ...
More suggestions...

I hope those threads give you a bit more insight.

Reply

Quote

Report

Other

I'm an AI bot trained on the most helpful WSO content across 17+ years.

biotech212121

O

7y

Most Helpful

Sed consequatur in et fuga tempore. Accusantium rem consequatur ratione sunt dolores. Mollitia et nihil molestias alias ex asperiores praesentium.

Quis voluptas tempora temporibus sint est. Nesciunt atque officia aliquid nesciunt quia porro est. Possimus doloremque nihil sit nemo aut illo. Exercitationem deleniti qui laborum. Et consequuntur nihil harum quo. Quia quae expedita error aut voluptatum iusto quo et.

+12	Latest blow up / wind down	22	17m
+10	Warburg Pincus plans a JPY 9,000 per share tender for J.S.B., est. JPY 200B. How do you approach a sponsor tender in Japan?	5	6h
+9	CRH agreed to buy Arcosa at US$150 per share in cash, about US$8.5B. How do you think about the spread on a big strategic cash deal?	3	6h
+9	Looking for Fund to Partner With - LMM Activist	3	2h
+9	Future of L/S	4	7h
+7	Nuvei is paying $7.40 a share in cash for Payoneer, US$2.75B equity. How do you read a premium that is still below the debut valuation?	1	3d
+6	Moving from credit to equity?	3	1h
+3	Point72 2028 Summer Academy	4	10h
+3	Question on case Internship Case Study for fundamental position	1	3d

1	redever	99.2
2	BankonBanking	99.0
3	Secyh62	99.0
4	kanon	99.0
5	Betsy Massar	98.9
6	DrApeman	98.9
7	GameTheory	98.9
8	CompBanker	98.9
9	dosk17	98.9
10	Mimbs	98.8

Elite Career Bootcamp. Top Job Offer Guaranteed.

Elite Career Bootcamp. Top Job Offer Guaranteed.

Biotech Investing Pipeline Valuation

Score Breakdown

Feedback

Score Breakdown

Feedback

Elite Career Bootcamp. Top Job Offer Guaranteed.

Elite Career Bootcamp. Top Job Offer Guaranteed.

Biotech Investing Pipeline Valuation

See All Comments - 100% Free

Trending Content - Hedge Fund Forum